BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31794280)

  • 1. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
    Maiese K
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
    Maiese K
    Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
    Maiese K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm.
    Maiese K
    Front Biosci (Landmark Ed); 2021 Sep; 26(9):614-627. PubMed ID: 34590471
    [No Abstract]   [Full Text] [Related]  

  • 5. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
    Maiese K
    Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
    Maiese K
    Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
    Maiese K
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
    Maiese K
    Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
    Maiese K
    Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Maiese K
    Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.
    Maiese K
    Curr Neurovasc Res; 2018; 15(4):367-371. PubMed ID: 30484407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
    Maiese K
    Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.
    Maiese K
    Int Rev Neurobiol; 2020; 155():1-35. PubMed ID: 32854851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK.
    Maiese K
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
    Maiese K
    J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights for Oxidative Stress and Diabetes Mellitus.
    Maiese K
    Oxid Med Cell Longev; 2015; 2015():875961. PubMed ID: 26064426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.